Twenty-Five Years Ofprogress in Bilirubin Metabolism

Total Page:16

File Type:pdf, Size:1020Kb

Twenty-Five Years Ofprogress in Bilirubin Metabolism Gut: first published as 10.1136/gut.19.6.481 on 1 June 1978. Downloaded from Gut, 1978, 19, 481-491 Twenty-five years of progress in bilirubin metabolism (1952-77) BARBARA H. BILLING From the Department of Medicine, Royal Free Hospital, Hampstead, London SUMMARY This review deals with the development of our understanding of the chemistry of bilirubin and its glucuronide derivatives during the years 1952-77. It examines the relation between haem metabolism and bilirubin formation and our present knowledge of hepatic transport of bilirubin. The heterogeneity of familial hyperbilirubinaemia is discussed. The progress made in our understanding of bilirubin 8) have significantly different physical properties so metabolism during the last 25 years is due to the that, unlike the naturally occurring lXo isomer, they combined activities of the biochemist, organic can be excreted directly into bile, without requiring chemist, mass spectroscopist, electron microscopist, modifications to their structure (Blanckaert et al., and cell biologist, as well as the hepatologist, surgeon, 1977). and haematologist. This multi-disciplinary approach With chemical treatment it is possible to cleave the has resulted in a better appreciation of the mech- unsymmetrical bilirubin lXoa molecule into pairs of anisms involved in the formation and excretion of dipyrrole methene units which then undergo random bilirubin. It is, therefore, now possible to describe in recombination to give mixtures of the isomers biochemical terms some of the abnormalities respon- bilirubin lllx, bilirubin 1Xoa, and bilirubin XIIlx sible for hyperbilirubinaemia and in some circum- (McDonagh and Assisi, 1972). Although bilirubin http://gut.bmj.com/ stances to introduce appropriate therapeutic measures IHix and bilirubin XIIIo are rarely found in nature, to modify the degree ofjaundice. it is important to appreciate that, under certain conditions, dipyrrole exchange occurs, as this Chemistry of bilirubin can influence the interpretation of data obtained when determining the structure of bile pigments Although bilirubin was isolated from bile by Stadler (Jansen, 1973; Heirwegh et al., 1975). as early as 1864 it was not until 1942 that Fischer When a solution of bilirubin is exposed to visible on September 29, 2021 by guest. Protected copyright. and Plieninger (1942) demonstrated that it had an light with wavelengths in the region of 430 to 470 nm open chain structure consisting of four pyrrole it undergoes photo-oxidation, due to the formation rings joined by three carbon bridges (Fig. 1). The of singlet oxygen (McDonagh, 1971); this results in sequence of the four methyl, two vinyl, and two the formation ofcolourless products whicharesoluble propionic side chains was identical with that found in water. A similar reaction is thought to occur in the in the proptoporphyrin IX ring of haem after re- skin of jaundiced infants during phototherapy. In moval of carbon at the ax methene bridge, so it was addition, experiments in the Gunn rat suggest that, designated bilirubin IXcx. It has now been established during treatment, bilirubin may be temporarily that the terminal pyrrole rings exist predominantly converted from the 'trans' (Z) to the 'cis' (E) form in the lactam form (Hutchinson et al., 1971). The (Bonnett et al., 1976), which is free of hydrogen linear structure of the molecule would favour a bonding and therefore capable of being excreted compound with polar properties but this is not the directly into the bile (Ostrow, 1971; Zenone et al. case at a physiological pH and an explanation for 1977). the lipid solubility of bilirubin has long been sought. It was first postulated by Fog and Jellum (1963) that Identification of bilirubin derivatives there was strong intramolecular hydrogen bonding and recently Bonnett et al. (1976), using x-ray 'INDIRECT' AND 'DIRECT' BILIRUBIN analysis, have demonstrated that the molecule is stabilised by six intramolecular hydrogen bonds With the use of the Van den Bergh reaction for the (Fig. 2). The other three bilirubin isomers (fi, y, and measurementof bilirubin (Vanden Bergh and Muller, 481 Gut: first published as 10.1136/gut.19.6.481 on 1 June 1978. Downloaded from 482 Barbara H. Billing C-OH *HOC I I CHI CH2 CH2 CHI . l I I CH$ CH CH5 CH2 CH1 CH5 CHOCH H H H H H H H BILIRU BIN Diazonium salt of ~0 ethyl anthranilate 0 C OH C-OH ~~~~~~~~~~~~~~~~~~~I CH2 CH2 CH2 CHi. 11I CH CH2 CH CH3 CH3 CH2 1tO H H H Vinyl isomer of azopigment A Iso-vinyl isomer azopigment A http://gut.bmj.com/ Fig. 1 Coupling ofbilirubin with the diazonium salt ofethyl anthranilate to form two isomeric azo pigments (A or a,,) Asterisk indicates site ofconjugate formation. The glucuronide conjugates of azopigment A have been designated azopigment B (or 8). obstructive jaundice gave a 'direct' reaction in the test. It was therefore concluded that the liver produced a change in the bilirubin molecule in the course of its passage through the organ into the bile on September 29, 2021 by guest. Protected copyright. ducts. Whether this involved alterations in the chemical structure of the molecule or was associated with differences in protein binding was not established until two bile pigment fractions were obtained free of protein and other biliary constituents from BILIRUBIN IX d obstructive jaundice serum (Cole and Lathe, 1953). Fig. 2 Structure of bilirubin (Bonnett et al., 1976) rings A nd B lie in one plane and rings Cand D in another. BILIRUBIN GLUCURONIDES Dotted lines indicate six intramolecular hydrogen bonds (two sets, each involving a carboxylic group, Using reverse phase chromatography it was shown pyrrole-amino hydrogen, and a terminal lactam system.) that 'direct' bilirubin was a mixture of two pigments, arbitrarily called pigments I and II (Cole et al., 1954). Identification of these pigments was made possible 1916) in plasma it became evident that there were at using the stable azo pigments formed in the van den least two different types of bilirubin. The bilirubin in Bergh reaction as the result of an electrophilic ion the plasma of patients with haemolytic disease attacking the bilirubin at either side of the methylene required the presence of alcohol to give a positive bridge so that two dipyrroles are produced, which reaction with diazotised sulphanilic acid and was react covalently with the diazonium salt. It was considered to give an 'indirect' reaction. In contrast, shown that, whereas 'indirect' bilirubin gave rise to bile and plasma or urine from a patient with two molecules of azo-pyrrole A, the major 'direct Gut: first published as 10.1136/gut.19.6.481 on 1 June 1978. Downloaded from Twenty-five years ofprogress in bilirubin metabolism (1952-77) 483 reacting' pigment of bile (pigment II) formed two tetra pyrroles (Noir, 1976; Heirwegh et al., 1975; molecules of a more polar azo-pyrrole B. Purification Gordon et al., 1976) into mono and diconjugates of azo-pyrrole B by chromatography (Billing et al., most structural information has had to be derived 1957) revealed that it was the glucuronide of azo- from the analysis of the dipyrrolic azo-pigments, as pyrrole A. As the result of this observation and these are more stable and therefore more suitable for similar findings by other investigators (Talefant, such analytical techniques as mass spectrometry. 1956; Schmid, 1957) it was concluded that bilirubin It has been difficult to reconcile the findings of the was converted by the liver to a diglucuronide above investigators with those of Kuenzle (1970) ester. who, using reverse phase chromatography on As pigment I yielded equimolar amounts of azo- silicone treated columns for the isolation of azo- pyrroles A and B, it was postulated (Billing et al., pigments from 15 litres of human bile and very 1957) that bilirubin monoglucuronide was also precise analytical techniques, was unable to detect formed by the liver. Its existence as a chemical the presence of bilirubin glucuronide. Instead, entity was questioned for some years, as it was Kuenzle proposed that the major bilirubin con- somewhat unstable and, moreover, a complex of jugates in man were acidic disaccharides. New bilirubin and bilirubin diglucuronide would also light has, however, recently been shed on this prob- yield equimolar amounts of azo pigments A and B in lem by the observation that in aqueous solution the diazo reaction. The matter was finally resolved above pH7 bilirubin lXcs 1-0-acyl glucuronide when it was shown that two mono-amidederivatives of rapidly isomerises to non-C-1 glucuronides by bilirubin (Jansen and Billing, 1971) could be formed sequential migration of the bilirubin acyl group from from bile, which would be possible only if two position 1 to positions 2, 3, and 4 of the sugar isomers of bilirubin monoglucuronide were moiety (Compernolle et al., 1978). These non-C present. -1 glucuronides are not attacked by /-glucuronidase. When normal bile from man and rats is collected at OTHER BILIRUBIN CONJUGATES OOC and then immediately analysed it has been found that bilirubin lXcx mono- and diglucuronides With the development of a thin layer chromato- consist exclusively of 1-0-acyl isomers, and that 8 a graphic procedure with high resolving power for the azo-dipyrrole is the major azopigment formed http://gut.bmj.com/ analysis of azo pyrrole derivatives, Heirwegh and on diazotisation. If, however, the bile is incubated associates were able to show that the bile pigment at 370C or is obtained from rats or patients with pattern was considerably more complex (Heirwegh cholestasis (Fevery et al., 1972), then relatively large et al., 1970) than had previously been appreciated amounts of fi and y azopigments, which are and that there were significant species differences derived from 2-, 3-, and 4-0-acyl glucuronides (Fevery et al., 1977). With their techniques the (Blanckaert et al., 1978), are detected, thereby azo-pigments formed in a 'direct' reaction can be indicating that sequential migration of the on September 29, 2021 by guest.
Recommended publications
  • Hyperbilirubinemia
    Porphyrins Porphyrins (Porphins) are cyclic tetrapyrol compounds formed by the linkage )). of four pyrrole rings through methenyl bridges (( HC In the reduced porphyrins (Porphyrinogens) the linkage of four pyrrole rings (tetrapyrol) through methylene bridges (( CH2 )) The characteristic property of porphyrins is the formation of complexes with the metal ion bound to nitrogen atoms of the pyrrole rings. e.g. Heme (iron porphyrin). Proteins which contain heme ((hemoproteins)) are widely distributed e.g. Hemoglobin, Myoglobin, Cytochromes, Catalase & Tryptophan pyrrolase. Natural porphyrins have substituent side chains on the eight hydrogen atoms numbered on the pyrrole rings. These side chains are: CH 1-Methyl-group (M)… (( 3 )) 2-Acetate-group (A)… (( CH2COOH )) 3-Propionate-group (P)… (( CH2CH2COOH )) 4-Vinyl-group (V)… (( CH CH2 )) Porphyrins with asymmetric arrangement of the side chains are classified as type III porphyrins while those with symmetric arrangement of the side chains are classified as type I porphyrins. Only types I & III are present in nature & type III series is more important because it includes heme. 1 Heme Biosynthesis Heme biosynthesis occurs through the following steps: 1-The starting reaction is the condensation between succinyl-CoA ((derived from citric acid cycle in the mitochondria)) & glycine, this reaction is a rate limiting reaction in the hepatic heme synthesis, it occurs in the mitochondria & is catalyzed by ALA synthase (Aminolevulinate synthase) enzyme in the presence of pyridoxal phosphate as a cofactor. The product of this reaction is α-amino-β-ketoadipate which is rapidly decarboxylated to form δ-aminolevulinate (ALA). 2-In the cytoplasm condensation reaction between two molecules of ALA is catalyzed by ALA dehydratase enzyme to form two molecules of water & one 2 molecule of porphobilinogen (PBG) which is a precursor of pyrrole.
    [Show full text]
  • Porphyrins & Bile Pigments
    Bio. 2. ASPU. Lectu.6. Prof. Dr. F. ALQuobaili Porphyrins & Bile Pigments • Biomedical Importance These topics are closely related, because heme is synthesized from porphyrins and iron, and the products of degradation of heme are the bile pigments and iron. Knowledge of the biochemistry of the porphyrins and of heme is basic to understanding the varied functions of hemoproteins in the body. The porphyrias are a group of diseases caused by abnormalities in the pathway of biosynthesis of the various porphyrins. A much more prevalent clinical condition is jaundice, due to elevation of bilirubin in the plasma, due to overproduction of bilirubin or to failure of its excretion and is seen in numerous diseases ranging from hemolytic anemias to viral hepatitis and to cancer of the pancreas. • Metalloporphyrins & Hemoproteins Are Important in Nature Porphyrins are cyclic compounds formed by the linkage of four pyrrole rings through methyne (==HC—) bridges. A characteristic property of the porphyrins is the formation of complexes with metal ions bound to the nitrogen atom of the pyrrole rings. Examples are the iron porphyrins such as heme of hemoglobin and the magnesium‐containing porphyrin chlorophyll, the photosynthetic pigment of plants. • Natural Porphyrins Have Substituent Side Chains on the Porphin Nucleus The porphyrins found in nature are compounds in which various side chains are substituted for the eight hydrogen atoms numbered in the porphyrin nucleus. As a simple means of showing these substitutions, Fischer proposed a shorthand formula in which the methyne bridges are omitted and a porphyrin with this type of asymmetric substitution is classified as a type III porphyrin.
    [Show full text]
  • Bilirubin Metabolism (Lecture 8)
    Bilirubin Metabolism (Lecture 8) Excretory function of bile Bile is a medium for excretion of many substances as bile pigments, cholesterol, many drugs, toxins and various organic substances as copper and zinc. These substances are then eliminated in the feces. One of these substances excreted in bile is the greenish yellow pigment bilirubin. This is a major end product of hemoglobin degradation. It’s highly soluble in all cell membranes & is also very toxic. Therefore, its excretion in the bile is one of the very important functions of the liver. FATE OF RED BLOOD CELLS Life span of RBCs in blood stream is 60-120 days. Senescent RBCs become too fragile to exist longer in the circulatory system, their cell membranes rupture and they are phagocytosed and/or lysed. Normally, lysis occurs extravascularly in the reticuloendothelial system subsequent to RBC phagocytosis. Lysis can also occur intravascularly (in blood stream). The hemoglobin is first split into globin & heme. The AA formed from breakdown of globin are stored in the body. Metabolism of bilirubin The heme ring is opened to give: 1. Free iron that is transported in the blood by transferrin and stored in the body as a reservoir for erythropoiesis. 2. Bile pigments: The 1st pigment is biliverdin but it is rapidly reduced by biliverdin reductase to free bilirubin which is gradually released into the plasma. The free bilirubin is hydrophobic, immediately combines with plasma proteins (mainly albumin and globulin) forming a water soluble compound called hemobilirubin (unconjugated bilirubin) which is rapidly transported to hepatocytes for further metabolism. Even when bound to albumin it’s called free bilirubin.
    [Show full text]
  • Biochemistry I Enzymes
    BIOCHEMISTRY I 3rd. Stage Lec. ENZYMES Biomedical Importance: Enzymes, which catalyze the biochemical reactions, are essential for life. They participate in the breakdown of nutrients to supply energy and chemical building blocks; the assembly of those building blocks into proteins, DNA, membranes, cells, and tissues; and the harnessing of energy to power cell motility, neural function, and muscle contraction. The vast majority of enzymes are proteins. Notable exceptions include ribosomal RNAs and a handful of RNA molecules imbued with endonuclease or nucleotide ligase activity known collectively as ribozymes. The ability to detect and to quantify the activity of specific enzymes in blood, other tissue fluids, or cell extracts provides information that complements the physician’s ability to diagnose and predict the prognosis of many diseases. Further medical applications include changes in the quantity or in the catalytic activity of key enzymes that can result from genetic defects, nutritional deficits, tissue damage, toxins, or infection by viral or bacterial pathogens (eg, Vibrio cholerae). Medical scientists address imbalances in enzyme activity by using pharmacologic agents to inhibit specific enzymes and are investigating gene therapy as a means to remedy deficits in enzyme level or function. In addition to serving as the catalysts for all metabolic processes, their impressive catalytic activity, substrate specificity, and stereospecificity enable enzymes to fulfill key roles in additional processes related to human health and well-being. Proteases and amylases augment the capacity of detergents to remove dirt and stains, and enzymes play important roles in producing or enhancing the nutrient value of food products for both humans and animals.
    [Show full text]
  • NEONATAL Hb, O2-TRANSPORT & JAUNDICE: OVERVIEW
    BILIRUBIN METABOLISM & JAUNDICE UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ Temple 1 Brief description of Hemoglobin (Hb) structure • Hemoglobin (Hb): Made up of 4-Subunits (Tetramer) held together by multiple non-covalent interactions; • Each subunit consist of: • Heme (Ferro-Protoporphyrin), • Globin protein; • Heme: Protoporphyrin IX and Ferrous ion (Fe2); • Globin protein folds around Heme group forming a protective Hydrophobic pocket; • Heme is the site of Oxygen binding; 2 • There are different types of Hemoglobin, with different subunits: • Foetal Hemoglobin (Hb F): 2 2 Two types of Adult Hemoglobin (Hb A): • Hb A1 represented as: 2 2 • It is the major (98%) form of Hb in adults; • Hb A2 represented as: 2 2 • It is the minor (2%) form of Hb in adults; 3 What are the major sources of Heme in humans? • RBC is major source of Heme in humans, • Life span of RBC is about 120 days, • Other sources of Heme include: • Myoglobin (Mb): Stores Oxygen in muscle cells, • Cytochromes: present in some enzymes, • Catalase: an enzyme, 4 What normally happens to RBC after 120 days? • RBC is destroyed mainly in Reticuloendothelial system (Extra-vascular system: Spleen and Liver); • Daily turnover of Hb is about 6 g/day; • Hb is broken down, • Globin protein is hydrolyzed to amino acids, • Protoporphyrin Ring in Heme is Hydrophobic, thus must be made soluble before it is excreted, • Ferrous ion is removed and stored in Iron pool, for reuse, • Protoporphyrin ring is metabolized
    [Show full text]
  • Baseline Levels of Endogenous Compounds in the Caucasian Population S
    Feasibility assessment of PBPK modelling for Endogenous Compounds: Baseline levels of endogenous compounds in the Caucasian population S. Neuhoff, H.E. Humphries, H. K. Crewe, Z. E. Barter, and K. Rowland-Yeo Simcyp Ltd (a Certara company), Blades Enterprise Centre, Sheffield, S2 4SU [email protected] BACKGROUND RESULTS (cont) RESULTS (cont) • There is increasing interest in the • Bilirubin and glucuronides 27-Hydroxycholesterol potential utility of Endogenous Cholesterol 1g/day A schematic of the formation and Compounds (EC’s) as biomarkers for CYP7A1 (liver) 500 mg/day CYP27A1 (many tissues) breakdown of bilirubin is shown in assessment of drug-induced enzyme 19 mg/day Figure 4. Total serum bilirubin (bilirubin 7α-Hydroxycholesterol level/activity changes of (a) CYP3A or CYP3A4 + bilirubin glucuronide), conjugated and Bile Acids (b) UGT1A1 following chronic dosing of 4-Hydroxycholesterol unconjugated plasma levels reflect the drug of interest. CYP27A1 (liver and extrahepatic) 24S-Hydroxycholesterol protein changes differently. • In July 2013, Consortium Members Pregnenolone were asked to identify a series of EC’s 4,27-Dihydroxycholesterol Macrophage CYP27A1 • Biliverdin reductase reduces Heme Hemeoxygenase for further evaluation, with a view to 4,24-Dihydroxycholesterol Biliverdin to unconjugated, water- Biliverdin 4,7α-Dihydroxycholesterol insoluble Bilirubin, which is Biliverdin reductase implementation within the Simcyp Bilirubin carried in blood bound to serum Unconjugated bilirubin Simulator. albumin complexed with albumin 3
    [Show full text]
  • Bilirubin PDF 12Days
    Bilirubin Physiology – WYNTKFTB • Bilirubin metabolism – Unconjugated – Conjugation – Excretion • Enterohepatic circulation • Implication of bilirubin metabolism – Urine – Stool • Understand the metabolic pathway as related to the disease state of JAUNDICE Don’t make me come up there and steal your google machines! BR - Alb Thank you. BG the Bilirubin an overview by howard sachs Slo-Motion Instant Replay… Heme oxygenase Biliverdin Reductase Heme oxygenase Biliverdin Reductase Bilirubin Albumin (unconjugated) …not water soluble… Unconjugated Bilirubin (‘Indirect’) Key points: • ‘Attached to albumin’: too big to pass through glomerular filtration barrier. • Intravascular: Hemoglobin ® urine • Unconjugated: not water soluble. How can we get too much unconjugated bilirubin in the serum? 1. Hemolysis • Elevated indirect bilirubin is used as a diagnostic marker (with ­ LDH, ¯ haptoglobin) 2. Conjugation defect: inherited (Gilbert’s, Crigler-Najjar) Multidrug resistance associated protein Bilirubin binds to cytosolic binding protein, glutathione s-transferase (GST) for transport to ER Conjugation of bilirubin is catalyzed by bilirubin-uridinediphosphate (UDP)- glucuronosyltransferase (UGT1A1). Product is bilirubin diglucuronide. UDPGA is the donor sugar Multidrug resistance Endoplasmic reticulum associated protein Bilirubin diglucuronide Conjugated (direct) Bilirubin binds to cytosolic binding protein, glutathione s-transferase (GST) for transport to ER Conjugation of bilirubin is catalyzed by bilirubin-uridinediphosphate (UDP)- glucuronosyltransferase
    [Show full text]
  • Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors
    Pharmaceutics 2011 , 3, 615-635; doi:10.3390/pharmaceutics3030615 OPEN ACCESS pharmaceutics ISSN 1999-4923 www.mdpi.com/journal/pharmaceutics Review Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors Toshihisa Ishikawa 1,*, Kenkichi Takahashi 2, Naokado Ikeda 2, Yoshinaga Kajimoto 2, Yuichiro Hagiya 3, Shun-ichiro Ogura 3, Shin-ichi Miyatake 2 and Toshihiko Kuroiwa 2 1 Omics Science Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan 2 Department of Neurosurgery, Osaka Medical College, Osaka 569-8686, Japan 3 Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama 226-8501, Japan * Author to whom correspondence should be addressed: E-Mail: [email protected]; Tel.: +81-45-503-9222; Fax: +81-45-503-9216. Received: 19 July 2011; in revised form: 16 August 2011 / Accepted: 9 September 2011 / Published: 14 September 2011 Abstract: Photodynamic diagnosis (PDD) is a practical tool currently used in surgical operation of aggressive brain tumors, such as glioblastoma. PDD is achieved by a photon-induced physicochemical reaction which is induced by excitation of protoporphyrin IX (PpIX) exposed to light. Fluorescence-guided gross-total resection has recently been developed in PDD, where 5-aminolevulinic acid (ALA) or its ester is administered as the precursor of PpIX. ALA induces the accumulation of PpIX, a natural photo-sensitizer, in cancer cells. Recent studies provide evidence that adenosine triphosphate (ATP)-binding cassette (ABC) transporter ABCG2 plays a pivotal role in regulating the cellular accumulation of porphyrins in cancer cells and thereby affects the efficacy of PDD.
    [Show full text]
  • Bilirubin Secretion, Jaundice and Evaluation of Liver Function
    Bilirubin Secretion, Jaundice and Evaluation of Liver Function Howard J. Worman, M. D. Evaluation of Liver Disease and Hepatic Function History Physical Examination Laboratory Tests Sometimes Radiological/Nuclear Medicine Sometimes Liver Biopsy 1 Jaundice occurs as a result of excess bilirubin in the blood. It is a hallmark of liver disease but not always present in liver disease. Jaundice occurs when the liver fails to adequately secrete bilirubin from the blood into the bile. To understand how jaundice occurs, you must first understand bilirubin synthesis, metabolism and secretion. 2 Heme Oxygenase Schuller et al. Nature Structural Biology 6, 860 - 867 (1999) Bilivirdin Reductase Kikuchi et al. Nature Structural Biology 8, 221 - 225 (2001) 3 Bilirubin is frequently depicted as a linear tetrapyrrole. However, intramolecular hydrogen bonding fixes it in a rigid structure that blocks exposure of its polar groups to aqueous solvents, making it very insoluble in blood. 4 Bilirubin in Blood is Bound to Albumin: Uptake into Hepatocyte at Basolateral (Sinusoidal) Membrane Some OATP-C? bilirubin stored in cytosol bound to proteins Bilurubin UDP-glucuronosyltransferase is localized to the endo- plasmic reticulum; it catalyzes conjugation to a diglucuronide, making it more water soluble. A: Labeling of periphery of cell hepatocyte nucleus B: Labeling of ER with antibody to UDP-glucuronosyltransferase 5 Alternative RNA splicing of different first exons of UGT1 gives different isoforms with different substrate specificities, some for bilirubin and others
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2001/0034023 A1 Stanton, JR
    US 2001.0034O23A1. (19) United States (12) Patent Application Publication (10) Pub. No.: US 2001/0034023 A1 Stanton, JR. et al. (43) Pub. Date: Oct. 25, 2001 (54) GENE SEQUENCE VARIATIONS WITH Related U.S. Application Data UTILITY IN DETERMINING THE (63) Continuation-in-part of application No. 09/710,467, TREATMENT OF DISEASE, INGENES filed on Nov. 8, 2000, which is a continuation-in-part RELATING TO DRUG PROCESSING of application No. 09/696,482, filed on Oct. 24, 2000. Non-provisional of provisional application No. 60/131,334, filed on Apr. 26, 1999. Non-provisional (76) Inventors: Vincent P. Stanton JR., Belmont, MA of provisional application No. 60/139,440, filed on (US); Martin Zillmann, Shrewsbury, Jun. 15, 1999. MA (US) (30) Foreign Application Priority Data Correspondence Address: Jan. 20, 2000 (WO)........................... PCT/USOO/O1392 EDWARD O. KRUESSER BROBECK PHLEGER & HARRISON Publication Classification 12390 EL CAMINO REAL (51) Int. Cl. ............................. C12O 1/68; G06F 19/00 SAN DIEGO, CA 92130 (US) (52) U.S. Cl. ................................................... 435/6; 702/20 (57) ABSTRACT (21) Appl. No.: 09/733,000 Methods for identifying and utilizing variances in genes relating to efficacy and Safety of medical therapy and other aspects of medical therapy are described, including methods (22) Filed: Dec. 7, 2000 for Selecting an effective treatment. US 2001/0034023 A1 Oct. 25, 2001 GENE SEQUENCE WARIATIONS WITH UTILITY 0005 For some drugs, over 90% of the measurable IN DETERMINING THE TREATMENT OF interSubject variation in Selected pharmacokinetic param DISEASE, INGENES RELATING TO DRUG eters has been shown to be heritable. For a limited number PROCESSING of drugs, DNA sequence variances have been identified in Specific genes that are involved in drug action or metabo RELATED APPLICATIONS lism, and these variances have been shown to account for the 0001.
    [Show full text]
  • Inherited Disorders of Bilirubin Clearance N
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Hofstra Northwell Academic Works (Hofstra Northwell School of Medicine) Donald and Barbara Zucker School of Medicine Journal Articles Academic Works 2015 Inherited disorders of bilirubin clearance N. Memon B. I. Weinberger Zucker School of Medicine at Hofstra/Northwell T. Hegyi L. M. Aleksunes Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles Part of the Pediatrics Commons Recommended Citation Memon N, Weinberger B, Hegyi T, Aleksunes L. Inherited disorders of bilirubin clearance. 2015 Jan 01; 79(3):Article 2776 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/2776. Free full text article. This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more information, please contact [email protected]. HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Pediatr Manuscript Author Res. Author manuscript; Manuscript Author available in PMC 2016 April 05. Published in final edited form as: Pediatr Res. 2016 March ; 79(3): 378–386. doi:10.1038/pr.2015.247. Inherited Disorders of Bilirubin Clearance Naureen Memon1,*, Barry I Weinberger2, Thomas Hegyi1, and Lauren M Aleksunes3 1Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA 2Department of Pediatrics, Cohen Children’s Medical Center of New York, New Hyde Park, NY, USA 3Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ, USA Abstract Inherited disorders of hyperbilirubinemia may be caused by increased bilirubin production or decreased bilirubin clearance.
    [Show full text]
  • Novel Pharmacogenomic Markers of Irinotecan-Induced Severe Toxicity in Metastatic Colorectal Cancer Patients
    Novel pharmacogenomic markers of irinotecan-induced severe toxicity in metastatic colorectal cancer patients Thèse Siwen Sylvialin Chen Doctorat en sciences pharmaceutiques Philosophiae doctor (Ph.D.) Québec, Canada © Siwen Sylvialin Chen, 2015 ii Résumé L’irinotécan est un agent de chimiothérapie largement utilisé pour le traitement de tumeurs solides, particulièrement pour le cancer colorectal métastatique (mCRC). Fréquemment, le traitement par l’irinotécan conduit à la neutropénie et la diarrhée, des effets secondaires sévères qui peuvent limiter la poursuite du traitement et la qualité de vie des patients. Plusieurs études pharmacogénomiques ont évalué les risques associés à la chimiothérapie à base d’irinotécan, en particulier en lien avec le gène UGT1A, alors que peu d’études ont examiné l’impact des gènes codant pour des transporteurs. Par exemple, le marqueur UGT1A1*28 a été associé à une augmentation de 2 fois du risque de neutropénie, mais ce marqueur ne permet pas de prédire la toxicité gastrointestinale ou l’issue clinique. L’objectif de cette étude était de découvrir de nouveaux marqueurs génétiques associés au risque de toxicité induite par l’irinotécan, en utilisant une stratégie d’haplotype/SNP-étiquette permettant de maximiser la couverture des loci génétiques ciblés. Nous avons analysé les associations génétiques des loci UGT1 et sept gènes codants pour des transporteurs ABC impliqués dans la pharmacocinétique de l’irinotécan, soient ABCB1, ABCC1, ABCC2, ABCC5, ABCG1, ABCG2 ainsi que SLCO1B1. Les profils de 167 patients canadiens atteints de mCRC sous traitement FOLFIRI (à base d’irinotécan) ont été examinés et les marqueurs significatifs ont par la suite été validés dans une cohorte indépendante de 250 patients italiens.
    [Show full text]